Nisibis LLC
Bone Marrow Research
Based in IN
🤖
AI Overview
With $10K in lobbying spend across 22 quarterly filings, Nisibis LLC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2025.
$10K
Total Spend
6
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $10K |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Nisibis LLC disclosed contacting in their lobbying filings.
Defense Advanced Research Projects Agency (DARPA)Defense, Dept of (DOD)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESNavy, Dept ofSENATE
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED
Research in bone marrow diseases using PTEN Inhibitors.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.